This drug has not been approved. Speculation, that's all this is. Look what happened in one day when the other drug was put on hold. $16.74 a share and in one day closed off to $11.00. If NBIX does not get approval look for another $5.00 a share loss from today's price. Nice run-up yesterday; why not take your profit and get back in after the disappointing setback about to come shortly that this drug too is not going to pass FDA approval.